Business Context and Reporting Period
Alterity Therapeutics Limited, a development stage enterprise based in Melbourne, Australia, filed this Form 6-K on January 8, 2024, covering the month of January 2024. The filing incorporates by reference into various Registration Statements (Forms S-8 and F-3).
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The document focuses on a capital raising event rather than periodic financial performance results.
Material Changes
- Capital Raise: Alterity Therapeutics completed Tranche Two of a placement, raising A$3.5 million.
Guidance, Outlook, and Risks
The filing text does not provide management commentary, future guidance, specific risk factors, or details on contingencies beyond the completion of the capital raise. No unusual items were disclosed in the provided text.
Investor Verification Checklist
- Verify the total aggregate amount raised across all tranches of the placement.
- Confirm the use of proceeds for the A$3.5 million raised in Tranche Two.
- Review the full text of Exhibit 99.1 for details on the placement terms and investor participation.
- Check subsequent filings for updated cash position and burn rate following this capital injection.